Remote ECG Monitoring to Reduce Complications following Transcatheter Aortic Valve Implantations
REdireCT TAVI is a feasibility study of patients booked for an outpatient transcatheter Aortic Valve Implantation (TAVI) procedure to assess implementation of remote loop monitoring as part of a strategy of standardized electrophysiology assessment pre- and post-TAVI. Patients will have continuous home monitoring using m-Health solutions m-CARDSTM system both pre- and post-TAVI procedure, in order to detect intermittent conduction abnormalities, such as heart block and atrial fibrillation. The primary objective of this study is to assess feasibility and patient and clinical team experience and to gather information useful for implementing a larger study for clinical outcomes including length of stay post-TAVR, arrhythmia related re-hospitalizations and cost-effectiveness.
Interventional Device Feasibility Study
Feasibility of enrollment; patient adherence to loop monitoring pre and post TAVI; pre-TAVI identification of cohort requiring permanent pacemaker; medical assessment within 24 hours of identified “serious” arrhythmia pre- or post-TAVI; positive rating on patient and clinical team experience surveys.
Dr. Madhu K. Natarajan (PI), Dr. Jeff Healey, Dr. Tej Sheth, Dr. Jon-David Schwalm, Dr. James Velianou, Dr. Warren Cantor, Dr. Harindra Wijeysundara